2011

    Creatine in Health and Disease

    Wallimann T, Tokarska-Schlattner M, Schlattner U

    Published in Molecular Aspects of Medicine

    Abstract

    Comprehensive review of creatine metabolism and its roles in health and disease, including energy metabolism and cellular protection.

    Methodology

    Comprehensive review of creatine and phosphocreatine biochemistry, the creatine kinase energy shuttle, and creatine supplementation across muscle, brain, cardiac and disease contexts.

    Key Findings

    Creatine and creatine kinase form an energy buffering and transport system that stabilises cellular ATP in tissues with high and fluctuating energy demand, notably skeletal muscle, heart and brain. Beyond ergogenic effects, the review describes antioxidant, anti-apoptotic and membrane-stabilising actions, and covers evidence for creatine in creatine-deficiency syndromes, neuromuscular and neurodegenerative disease, and muscle wasting. Oral creatine reliably raises intramuscular phosphocreatine.

    Conclusions

    Creatine is established as a safe and effective agent for increasing muscle phosphocreatine and performance, has proven value in inborn creatine deficiency syndromes, and has mechanistically plausible but clinically unconfirmed potential in neurological and cardiac disease.

    Limitations

    Narrative review without systematic search or pooled estimates; combines strong human ergogenic evidence with speculative therapeutic extrapolations from cell and animal models; clinical trials in neurodegenerative disease conducted since publication have largely been negative.

    Supplements Studied

    Creatine in health and disease.

    Outcomes Measured

    Creatine in health and disease.

    Creatine and creatine kinase form an energy buffering and transport system that stabilises cellular ATP in tissues with high and fluctuating energy demand, notably skeletal muscle, heart and brain. Beyond ergogenic effects, the review describes antioxidant, anti-apoptotic and membrane-stabilising actions, and covers evidence for creatine in creatine-deficiency syndromes, neuromuscular and neurodegenerative disease, and muscle wasting. Oral creatine reliably raises intramuscular phosphocreatine.

    Study Details

    Year:2011
    Quality Score:5/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.